Cardiovascular Diagnostic Biomarker Discovery Services

Cardiovascular biomarkers are useful for the early diagnosis and prognostic assessment of cardiovascular disease. Ace Therapeutics offers advanced cardiovascular disease biomarker identification and validation research services to help you get ahead in cardiovascular disease biomarker development.

Overview of Cardiovascular Biomarkers

Myocardial cell injury, cardiac decline, or cardiovascular inflammation can lead to altered integrity and increased permeability of cell membranes, allowing intracellular substances to enter the peripheral blood circulation, and these substances, which can be detected in the blood circulation, are known as cardiovascular biomarkers. Cardiovascular biomarkers can help in the early diagnostic and prognostic assessment of myocardial injury, especially acute myocardial infarction in coronary heart disease.

Fig. 1 Potential mechanisms underlying elevations in cardiac troponin. (Mueller C, et al., 2021)

With its high-end technology platform, Ace Therapeutics provides customers with cardiovascular biomarker discovery services to help researchers conduct in-depth studies of cardiovascular disease.

Cardiovascular Biomarker Discovery Services

Different types of cardiovascular biomarkers can reflect cardiac tissue damage, cardiac functional status and cardiovascular inflammation. We can provide different molecular types of cardiovascular biomarker development services according to our clients' individual research needs.

• Cardiovascular Biomarker Types We Can Develop
  • Proteins
  • MicroRNAs

  • Small Molecules
• Biomarker Discovery Platforms
  • Genomics Analysis Platform
  • Transcriptomics Analysis Platform

  • Proteomics Analysis Platform
  • Metabolomics Analysis Platform
• Data Analysis Methods
  • Performance Evaluation
  • Statistical Analysis

  • Multivariate Analysis
  • Visualization
• Biomarker Discovery Process
  we can receive sample materials from our clients and perform biomarker identification and analysis services using specific analytical methods according to the customized needs of the study.

Ace Therapeutics is a CRO dedicated to providing research outsourcing services for cardiovascular disease research and can provide in vitro diagnostic R&D services such as IVD reagent development and biomarker development solutions. If you are interested in our services, please don't hesitate to contact us.

Reference

1. Mueller, C.; et al. Cardiovascular biomarkers in patients with COVID-19. Eur Heart J Acute Cardiovasc Care. 2021, 10(3): 310-319.